HCM
Highfields Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-5,295,102
| Closed | -$83M | – | 11 |
|
2019
Q1 | $83M | Sell |
5,295,102
-6,500,000
| -55% | -$102M | 11.41% | 4 |
|
2018
Q4 | $182M | Sell |
11,795,102
-2,266,054
| -16% | -$34.9M | 8.57% | 3 |
|
2018
Q3 | $303M | Sell |
14,061,156
-13,038,477
| -48% | -$281M | 5.66% | 3 |
|
2018
Q2 | $659M | Sell |
27,099,633
-10,117,250
| -27% | -$246M | 7.25% | 3 |
|
2018
Q1 | $636M | Buy |
37,216,883
+2,464,556
| +7% | +$42.1M | 5.76% | 4 |
|
2017
Q4 | $659M | Buy |
34,752,327
+9,171,368
| +36% | +$174M | 5.47% | 4 |
|
2017
Q3 | $450M | Buy |
25,580,959
+4,205,045
| +20% | +$74M | 3.88% | 8 |
|
2017
Q2 | $710M | Buy |
21,375,914
+3,657,564
| +21% | +$122M | 5.26% | 4 |
|
2017
Q1 | $569M | Buy |
17,718,350
+850,903
| +5% | +$27.3M | 5.27% | 4 |
|
2016
Q4 | $611M | Buy |
16,867,447
+8,686,905
| +106% | +$315M | 5.07% | 4 |
|
2016
Q3 | $376M | Sell |
8,180,542
-5,368,983
| -40% | -$247M | 3.53% | 8 |
|
2016
Q2 | $681M | Buy |
13,549,525
+3,958,375
| +41% | +$199M | 5.93% | 1 |
|
2016
Q1 | $513M | Buy |
9,591,150
+1,098,246
| +13% | +$58.8M | 4.79% | 3 |
|
2015
Q4 | $557M | Buy |
8,492,904
+200,000
| +2% | +$13.1M | 4.8% | 4 |
|
2015
Q3 | $468M | Buy |
8,292,904
+3,824,550
| +86% | +$216M | 4.13% | 7 |
|
2015
Q2 | $264M | Sell |
4,468,354
-617,551
| -12% | -$36.5M | 2.37% | 13 |
|
2015
Q1 | $317M | Hold |
5,085,905
| – | – | 2.83% | 11 |
|
2014
Q4 | $292M | Sell |
5,085,905
-1,287,095
| -20% | -$74M | 2.49% | 14 |
|
2014
Q3 | $343M | Buy |
6,373,000
+186,000
| +3% | +$10M | 2.67% | 13 |
|
2014
Q2 | $324M | Buy |
6,187,000
+187,000
| +3% | +$9.8M | 2.38% | 11 |
|
2014
Q1 | $317M | Buy |
+6,000,000
| New | +$317M | 2.66% | 11 |
|
2013
Q3 | – | Sell |
-1,539,728
| Closed | -$60.4M | – | 92 |
|
2013
Q2 | $60.4M | Buy |
+1,539,728
| New | +$60.4M | 0.5% | 48 |
|